Literature DB >> 20930172

Activation of protease-activated receptors 3 and 4 accelerates tissue factor-induced thrombin generation on the surface of vascular smooth muscle cells.

Param Vidwan1, Alokkumar Pathak, Samar Sheth, Jianhua Huang, Dougald M Monroe, George A Stouffer.   

Abstract

OBJECTIVE: To determine factors regulating human aortic smooth muscle cells (HASMC) supported tissue factor-induced thrombin generation. METHODS AND
RESULTS: The addition of nonlipidated tissue factor and Ca(2+) to HASMCs maintained in reptilase-treated platelet-poor plasma resulted in the robust formation of thrombin after a lag phase of approximately 6 minutes. Pretreatment with low concentrations of α-thrombin before the addition of tissue factor and Ca(2+) accelerated the rate of thrombin generation (time to reach half of peak thrombin was reduced by [mean ± SD] 42.0 ± 2.2%; P<0.05) but had no effect on the amount of peak thrombin generated. Protease-activated receptor (PAR) 3 activating peptides (APs) or PAR-4 APs accelerated thrombin generation without affecting peak thrombin levels (time to half of peak thrombin decreased by 17.4 ± 5.6% and 21.7 ± 3.5%; P<0.05 with PAR-3 AP and PAR-4 AP, respectively). The addition of PAR-3 AP and PAR-4 AP together had an additive effect, with a reduction in time to half of peak thrombin of 43.9 ± 4.0%. PAR-3 AP or PAR-4 AP enhanced tissue factor-induced factor Xa production and phosphatidylserine exposure on the surface of HASMCs. PAR-1 activation had no effect on thrombin generation, factor Xa production, or phosphatidylserine exposure.
CONCLUSIONS: Low concentrations of α-thrombin accelerate tissue factor-induced thrombin generation on the surface of HASMCs, and this effect is mediated by PAR-3 and PAR-4.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20930172      PMCID: PMC3426369          DOI: 10.1161/ATVBAHA.110.211177

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  27 in total

Review 1.  The dynamics of thrombin formation.

Authors:  Kenneth G Mann; Saulius Butenas; Kathleen Brummel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-01       Impact factor: 8.311

Review 2.  Platelets and thrombin generation.

Authors:  Dougald M Monroe; Maureane Hoffman; Harold R Roberts
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-09-01       Impact factor: 8.311

3.  Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets.

Authors:  L Covic; A L Gresser; A Kuliopulos
Journal:  Biochemistry       Date:  2000-05-09       Impact factor: 3.162

4.  Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque.

Authors:  Natalya M Ananyeva; Diana V Kouiavskaia; Midori Shima; Evgueni L Saenko
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

Review 5.  New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology.

Authors:  C Patterson; G A Stouffer; N Madamanchi; M S Runge
Journal:  Circ Res       Date:  2001-05-25       Impact factor: 17.367

6.  Evidence for functionally active protease-activated receptor-4 (PAR-4) in human vascular smooth muscle cells.

Authors:  E Bretschneider; R Kaufmann; M Braun; G Nowak; E Glusa; K Schrör
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

Review 7.  Tissue factor in coagulation: Which? Where? When?

Authors:  Saulius Butenas; Thomas Orfeo; Kenneth G Mann
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-10       Impact factor: 8.311

8.  Evidence for functionally active protease-activated receptor-3 (PAR-3) in human vascular smooth muscle cells.

Authors:  Ellen Bretschneider; Rainer Spanbroek; Katharina Lötzer; Andreas Johann Richard Habenicht; Karsten Schrör
Journal:  Thromb Haemost       Date:  2003-10       Impact factor: 5.249

9.  Alphavbeta3-integrin antagonists inhibit thrombin-induced proliferation and focal adhesion formation in smooth muscle cells.

Authors:  M Sajid; R Zhao; A Pathak; S S Smyth; G A Stouffer
Journal:  Am J Physiol Cell Physiol       Date:  2003-07-23       Impact factor: 4.249

Review 10.  Antithrombotics in acute coronary syndromes.

Authors:  Marc P Bonaca; Philippe Gabriel Steg; Laurent J Feldman; John F Canales; James J Ferguson; Lars Wallentin; Robert M Califf; Robert A Harrington; Robert P Giugliano
Journal:  J Am Coll Cardiol       Date:  2009-09-08       Impact factor: 24.094

View more
  5 in total

Review 1.  Optimal use of platelet glycoprotein IIb/IIIa receptor antagonists in patients undergoing percutaneous coronary interventions.

Authors:  H Benjamin Starnes; Ankit A Patel; George A Stouffer
Journal:  Drugs       Date:  2011-10-22       Impact factor: 9.546

Review 2.  Thrombin and vascular inflammation.

Authors:  Milan Popović; Katarina Smiljanić; Branislava Dobutović; Tatiana Syrovets; Thomas Simmet; Esma R Isenović
Journal:  Mol Cell Biochem       Date:  2011-08-23       Impact factor: 3.396

Review 3.  Protease-activated receptor 4: from structure to function and back again.

Authors:  Shauna L French; Justin R Hamilton
Journal:  Br J Pharmacol       Date:  2016-03-10       Impact factor: 8.739

4.  Platelets differentially modulate CD4+ Treg activation via GPIIa/IIIb-, fibrinogen-, and PAR4-dependent pathways.

Authors:  Matthias Bock; Christian B Bergmann; Sonja Jung; Peter Biberthaler; Laura Heimann; Marc Hanschen
Journal:  Immunol Res       Date:  2021-12-21       Impact factor: 2.829

5.  Thrombin stimulates insulin secretion via protease-activated receptor-3.

Authors:  Sonja Hänzelmann; Jinling Wang; Emre Güney; Yunzhao Tang; Enming Zhang; Annika S Axelsson; Hannah Nenonen; Albert S Salehi; Claes B Wollheim; Eva Zetterberg; Erik Berntorp; Ivan G Costa; Robert Castelo; Anders H Rosengren
Journal:  Islets       Date:  2015       Impact factor: 2.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.